pI: 6.6923 |
Length (AA): 726 |
MW (Da): 82259 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 11
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128399)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G17250 | alkaline-phosphatase-like protein |
Brugia malayi | Bm1_22750 | hypothetical protein |
Candida albicans | CaO19.833 | similar to C terminus of GPI13, GPI anchor synthesis |
Candida albicans | CaO19.832 | truncated form of GPI13, GPI anchor synthesis |
Candida albicans | CaO19.8452 | truncated form of GPI13, GPI anchor synthesis |
Candida albicans | CaO19.8453 | similar to C terminus of GPI13, GPI anchor synthesis |
Caenorhabditis elegans | CELE_C27A12.9 | Protein C27A12.9 |
Cryptosporidium hominis | Chro.80266 | CG12263 gene product-related |
Cryptosporidium parvum | cgd8_2260 | phosphatidylinositol glycan class O, integral membrane protein with signal peptide sequence and 12 or more transmembrane domains |
Dictyostelium discoideum | DDB_G0278687 | phosphatidylinositol glycan, class O |
Drosophila melanogaster | Dmel_CG12263 | CG12263 gene product from transcript CG12263-RA |
Echinococcus granulosus | EgrG_001186800 | gpi ethanolamine phosphate transferase 3 |
Entamoeba histolytica | EHI_035390 | phosphatidylinositol-glycan biosynthesis class O protein, putative |
Entamoeba histolytica | EHI_107320 | phosphatidylinositol-glycan biosynthesis class O protein, putative |
Echinococcus multilocularis | EmuJ_001186800 | gpi ethanolamine phosphate transferase 3 |
Homo sapiens | ENSG00000165282 | phosphatidylinositol glycan anchor biosynthesis, class O |
Leishmania braziliensis | LbrM.24.0340 | ethanolamine phosphotransferase, putative |
Leishmania donovani | LdBPK_240330.1 | ethanolamine phosphotransferase, putative |
Leishmania infantum | LinJ.24.0330 | ethanolamine phosphotransferase, putative |
Leishmania major | LmjF.24.0340 | ethanolamine phosphotransferase, putative |
Leishmania mexicana | LmxM.24.0340 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_03903 | hypothetical protein |
Mus musculus | ENSMUSG00000028454 | phosphatidylinositol glycan anchor biosynthesis, class O |
Oryza sativa | 4348186 | Os10g0170300 |
Onchocerca volvulus | OVOC1248 | GPI ethanolamine phosphate transferase 3 homolog |
Plasmodium berghei | PBANKA_1429900 | GPI ethanolamine phosphate transferase 3, putative |
Plasmodium falciparum | PF3D7_1214100 | GPI ethanolamine phosphate transferase 3, putative |
Plasmodium knowlesi | PKNH_1433600 | GPI ethanolamine phosphate transferase 3, putative |
Plasmodium yoelii | PY02021 | Drosophila melanogaster CG12263 gene product-related |
Plasmodium yoelii | PY02022 | hypothetical protein |
Saccharomyces cerevisiae | YLL031C | Gpi13p |
Schistosoma japonicum | Sjp_0045610 | ko:K05288 phosphatidylinositol glycan, class O, putative |
Schistosoma mansoni | Smp_021980 | hypothetical protein |
Schmidtea mediterranea | mk4.002558.03 | |
Trypanosoma brucei gambiense | Tbg972.11.5730 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.5070 | GPI ethanolamine phosphate transferase 3, putative |
Theileria parva | TP01_0169 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.2720 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.2720 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.2720 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.2720 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YLL031C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1429900 | Plasmodium berghei | Essential | plasmo |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.